Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Incannex Healthcare (IXHL) EBITDA (2023 - 2025)

Historic EBITDA for Incannex Healthcare (IXHL) over the last 3 years, with Q3 2025 value amounting to -$6.2 million.

  • Incannex Healthcare's EBITDA fell 2156.86% to -$6.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$47.8 million, marking a year-over-year decrease of 11347.77%. This contributed to the annual value of -$46.7 million for FY2025, which is 15194.22% down from last year.
  • As of Q3 2025, Incannex Healthcare's EBITDA stood at -$6.2 million, which was down 2156.86% from -$31.3 million recorded in Q2 2025.
  • Over the past 5 years, Incannex Healthcare's EBITDA peaked at -$1.2 million during Q3 2023, and registered a low of -$31.3 million during Q2 2025.
  • Over the past 3 years, Incannex Healthcare's median EBITDA value was -$6.1 million (recorded in 2024), while the average stood at -$7.9 million.
  • The largest annual percentage gain for Incannex Healthcare's EBITDA in the last 5 years was 4079.7% (2025), contrasted with its biggest fall of 40945.4% (2025).
  • Over the past 3 years, Incannex Healthcare's EBITDA (Quarter) stood at -$4.3 million in 2023, then crashed by 46.22% to -$6.3 million in 2024, then increased by 1.71% to -$6.2 million in 2025.
  • Its EBITDA stands at -$6.2 million for Q3 2025, versus -$31.3 million for Q2 2025 and -$4.1 million for Q1 2025.